About Our Research Program
Under the direction of division chief Jeffrey M. Jacobson, M.D., the Division of Infectious Diseases and HIV Medicine is expanding our translational research program, and investigating cutting-edge technologies, vaccines, and therapeutic treatments for the management and prevention of HIV and other infectious diseases. Current and pending research studies involve close collaborations with DUCOM's Department of Microbiology and Immunology, and Department of Emergency Medicine, as well as the Drexel University School of Public Health.
Michele Kutzler, Ph.D., is currently investigating the development of DNA vaccines, therapeutics to treat Clostridium difficile, and the immune responses of intravenous drug users. In addition, her lab processes specimens from the Division's clinical research studies. See Dr. Kutzler's bio.
These are some of our current clinical studies. Participants who are entered into any of the studies will be compensated for time, travel, and meals. Please contact Sharon Lewis, R.N., at 215-762-3251.
Dendritic Vaccine Study
Purpose: To establish a group of subjects in an anti-HIV medication study for the purposes of making a personalized HIV vaccine
Summary: Patient's own virus will be mixed with dendritic cells to make a customized vaccine
- HIV-infected men or women
- Age: 18-60
- CD4: greater than 200 within 30 days prior to study entry
- Viral load: greater than 8,000
- Have been off antirretroviral medications for at least 12 weeks prior to study
- Have had a positive test for hepatitis C or B
- No current evidence of active syphilis
Please contact Sharon Lewis, R.N., at 215-762-3251.
Back to Top